Search results for "Molecular target"

showing 10 items of 187 documents

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

2016

Cellular organelles provide opportunities to relate biological mechanisms to disease. Here we use affinity proteomics, genetics and cell biology to interrogate cilia: poorly understood organelles, where defects cause genetic diseases. Two hundred and seventeen tagged human ciliary proteins create a final landscape of 1,319 proteins, 4,905 interactions and 52 complexes. Reverse tagging, repetition of purifications and statistical analyses, produce a high-resolution network that reveals organelle-specific interactions and complexes not apparent in larger studies, and links vesicle transport, the cytoskeleton, signalling and ubiquitination to ciliary signalling and proteostasis. We observe sub…

Proteomics0301 basic medicineSystems AnalysisDNA Mutational Analysislnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]General Physics and AstronomyDatasets as Topicmethods [Chromatography Affinity]ProteomicsSensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]Chromatography AffinityMass SpectrometryProtein Interaction Mappingtherapy [Ciliopathies]genetics [Ciliopathies]methods [Molecular Targeted Therapy]Molecular Targeted TherapyProtein Interaction MapsMultidisciplinaryCiliumChemistry (all)Qabnormalities [Spine]pathology [Ciliopathies]genetics [Muscle Hypotonia]therapy [Muscle Hypotonia]Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]metabolism [Proteins]isolation & purification [Proteins]physiology [Biological Transport]3. Good healthCell biologyVesicular transport proteinpathology [Dwarfism]metabolism [Cilia]Muscle Hypotoniaddc:500pathology [Muscle Hypotonia]pathology [Spine]genetics [Dwarfism]Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]ScienceDwarfismExocystBiologyArticleGeneral Biochemistry Genetics and Molecular BiologyPhysics and Astronomy (all)03 medical and health sciencesIntraflagellar transportCiliogenesisOrganelleHumansCiliaBiochemistry Genetics and Molecular Biology (all)ProteinsBiological TransportGeneral Chemistrytherapy [Dwarfism]Fibroblastsgenetics [Proteins]CiliopathiesSpinemethods [Protein Interaction Mapping]Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]030104 developmental biologyProteostasisHEK293 Cellsmethods [Proteomics]
researchProduct

Translational Approaches In Cardiovascular Diseases by Omics.

2017

Cardiovascular diseases are among the leading causes of morbidity and mortality. Despite scientific and technical progress in risk prediction, diagnostics, prognostication and therapy of cardiovascular pathologies, new biomarkers and therapeutic targets remain the subject of intense research to reduce the burden of these diseases. High throughput analyses, termed "omics", are a promising avenue of research. These recently developed technical fields have revolutionized biological and medical research in a very short time. By their interdisciplinary nature, these new methods have already provided a wide vision of cell and tissue pathways and functions. Here, we review how these methods can he…

ProteomicsProteomics methodsbusiness.industryMEDLINEGeneral MedicineComputational biologyGenomics030204 cardiovascular system & hematologyMedical researchOmics030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineCardiovascular DiseasesMedicineHumansMolecular Targeted TherapybusinessBiomarkersCurrent issues in molecular biology
researchProduct

Irinotecan or oxaliplatin: Which is the first move for the mate?

2020

Objectives: The aim of the present review is to discuss the potential link between RAS, BRAF and microsatellite instability (MSI) mutational patterns and chemotherapeutic agent efficacy [Irinotecan (IRI) vs. Oxaliplatin (OXA)], and how this can potentially influence the choice of the chemotherapy backbone. Methods: Following a review of the research literature, all pertinent articles published in the core journals were selected for the study. The inclusion criteria regarded relevant clinical and pre-clinical studies on the topic of interest (Relationship of OXA and IRI to KRAS/BRAF mutations and MSI). Results: Excision repair cross complementation group 1 (ERCC1) expression is inhibited by…

Proto-Oncogene Proteins B-rafColorectal cancerPopulationmedicine.disease_causeIrinotecanBiochemistryDNA Mismatch RepairSettore MED/06BRAFDrug DiscoveryKRASMedicineChemotherapyHumanseducationMSIPharmacologyeducation.field_of_studybusiness.industryOrganic ChemistryMicrosatellite instabilitymedicine.diseaseColorectal cancerdigestive system diseasesOxaliplatinIrinotecanOxaliplatinGenes rasMutationCancer researchMolecular MedicineMolecular targetsDNA mismatch repairMicrosatellite InstabilityKRASERCC1businessColorectal Neoplasmsmedicine.drug
researchProduct

O1‐11‐06: Presenilin is the molecular target of both acidic and non‐acidic gamma‐secretase modulators

2012

Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceBiochemistryEpidemiologyChemistryHealth PolicyMolecular targetsNeurology (clinical)Geriatrics and GerontologyGamma secretasePresenilinAlzheimer's & Dementia
researchProduct

Molecular chaperones and mirnas in epilepsy: Pathogenic implications and therapeutic prospects

2021

Epilepsy is a pathologic condition with high prevalence and devastating consequences for the patient and its entourage. Means for accurate diagnosis of type, patient monitoring for predicting seizures and follow up, and efficacious treatment are desperately needed. To improve this adverse outcome, miRNAs and the chaperone system (CS) are promising targets to understand pathogenic mechanisms and for developing theranostics applications. miRNAs implicated in conditions known or suspected to favor seizures such as neuroinflammation, to promote epileptic tolerance and neuronal survival, to regulate seizures, and others showing variations in expression levels related to seizures are promising ca…

QH301-705.5Adverse outcomesReviewDiseaseBioinformaticsCatalysisInorganic ChemistryEpilepsychaperone systemmicroRNAmedicineAnimalsHumansBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologyHeat-Shock ProteinsSpectroscopyNeuroinflammationmiRNAHigh prevalencebiologybusiness.industryOrganic Chemistrymolecular chaperonesGeneral Medicinetemporal lobe epilepsymedicine.diseaseComputer Science ApplicationsMicroRNAsChemistryChaperone (protein)Molecular targetsbiology.proteinepilepsyAnticonvulsantsbusiness
researchProduct

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.

2021

Interstitial lung diseases (ILDs) include a large number of diseases and causes with variable outcomes often associated with progressive fibrosis. Although each of the individual fibrosing ILDs are rare, collectively, they affect a considerable number of patients, representing a significant burden of disease. Idiopathic pulmonary fibrosis (IPF) is the typical chronic fibrosing ILD associated with progressive decline in lung. Other fibrosing ILDs are often associated with connective tissues diseases, including rheumatoid arthritis-ILD (RA-ILD) and systemic sclerosis-associated ILD (SSc-ILD), or environmental/drug exposure. Given the vast number of progressive fibrosing ILDs and the dispariti…

QH301-705.5DiseaseReviewbehavioral disciplines and activitiesCatalysisextracellular HSPInorganic ChemistryIdiopathic pulmonary fibrosisFibrosisHeat shock proteinmedicineExtracellularAnimalsHumansinterstitial lung diseasesMolecular Targeted TherapyPhysical and Theoretical ChemistryBiology (General)Molecular BiologyQD1-999SpectroscopyHeat-Shock ProteinsLungbusiness.industryOrganic Chemistrylung fibrosisCancerGeneral Medicinerespiratory systemmedicine.diseaseIdiopathic Pulmonary FibrosisComputer Science Applicationsrespiratory tract diseasesbody regionsChemistrymedicine.anatomical_structureIPFImmunologyheat shock proteinsDisease ProgressionBiomarker (medicine)biomarkerbusinessLung Diseases InterstitialBiomarkersInternational journal of molecular sciences
researchProduct

Novel therapeutical approaches to managing atherosclerotic risk

2021

Atherosclerosis is a multifactorial vascular disease that leads to inflammation and stiffening of the arteries and decreases their elasticity due to the accumulation of calcium, small dense Low Density Lipoproteins (sdLDL), inflammatory cells, and fibrotic material. A review of studies pertaining to cardiometabolic risk factors, lipids alterations, hypolipidemic agents, nutraceuticals, hypoglycaemic drugs, atherosclerosis, endothelial dysfunction, and inflammation was performed. There are several therapeutic strategies including Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) inhibitors, inclisiran, bempedoic acid, Glucagon-Like Peptide-1 Receptor agonists (GLP-1 RAs), and nutraceuticals t…

QH301-705.5InflammationReview030204 cardiovascular system & hematologyPharmacologyCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineLipid oxidationmedicineAnimalsHumans030212 general & internal medicineMolecular Targeted TherapyPhysical and Theoretical ChemistryEndothelial dysfunctionBiology (General)Molecular BiologyQD1-999SpectroscopyInnovative therapiesMolecular signalingVascular diseasebusiness.industryPCSK9Organic ChemistryGeneral MedicineProprotein convertasemedicine.diseaseAtherosclerosisComputer Science ApplicationsManagementChemistryInflammationsAtheromaOxidative stressHypolipidemic Agentslipids (amino acids peptides and proteins)Nutraceuticalsmedicine.symptombusiness
researchProduct

Unmet needs and challenges in gastric cancer: The way forward

2014

AbstractAlthough the incidence of gastric cancer has fallen steadily in developed countries over the past 50years, outcomes in Western countries remain poor, primarily due to the advanced stage of the disease at presentation. While earlier diagnosis would help to improve outcomes for patients with gastric cancer, better understanding of the biology of the disease is also needed, along with advances in therapy. Indeed, progress in the treatment of gastric cancer has been limited, mainly because of its genetic complexity and heterogeneity. As a result, there is an urgent need to apply precision medicine to the management of the disease in order to ensure that individuals receive the most appr…

Quality Controlmedicine.medical_specialtyDrug developmentAuditDiseasePathogenesisMalignancyUnmet needsGastrectomyStomach NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRadiology Nuclear Medicine and imagingMolecular Targeted TherapyRegistriesIntensive care medicineQuality of Health CareRandomized Controlled Trials as Topicbusiness.industryIncidence (epidemiology)CancerGenomicsGeneral Medicinemedicine.diseasePrecision medicineSurgeryEuropeTreatmentOncologyRadiology Nuclear Medicine and imagingDrug DesignQuality of LifeHeterogeneitybusinessGastric cancerDelivery of Health CareDeveloped countryAlgorithms
researchProduct

QSAR multi-target in drug discovery: a review.

2013

The main purpose of the present review is to summarize the most significant works up to date in the field of multi-target QSAR (mt-QSAR), in order to emphasize the importance that this technique has acquired over the last decade. Unlike traditional QSAR techniques, mt-QSAR permits to calculate the probability of activity of a given compound against different biological or pharmacological targets. In simple terms, a single equation for multiple outputs. To emphasize more the importance of the mt-QSAR in the field of drug discovery, we also present a novel mt-QSAR model, made on purpose by our research group, for the prediction of the susceptibility of Gram + and Gram - anaerobic bacteria.

Quantitative structure–activity relationshipDrug discoveryQuantitative Structure-Activity RelationshipGeneral MedicineComputational biologyBiologyBioinformaticsMulti targetDrug DiscoverySingle equationMolecular MedicineAnimalsHumansAnaerobic bacteriaMolecular Targeted TherapyAlgorithmsProbabilityCurrent computer-aided drug design
researchProduct

Caveolin-1, breast cancer and ionizing radiation

2015

Breast cancer (BC) recovery has increased in recent years thanks to efforts of Omics-based research in this field. However, despite the important results obtained, BC remains a complex multifactorial pathology that is difficult to treat appropriately. Caveolin-1 (CAV1), the basic constituent protein of specialized plasma membrane invaginations called caveolae, is emerging as a potential therapeutic biomarker in BC. This factor may modulate BC response to chemotherapy and radiation therapy. In addition, recent reports describe the key role of CAV1 during cell response to oxidative stress. The aim of the present review was to describe the biological roles of CAV1 in BC considering its contras…

RadiotherapyAnimalCAV1; biomarker; breast cancer; ionizing radiation; review; Animals; Biomarkers Tumor; Breast Neoplasms; Caveolin 1; Cell Transformation Neoplastic; Female; Gene Expression Regulation Neoplastic; Humans; Molecular Targeted Therapy; Radiotherapy; Receptor Epidermal Growth Factor; Radiation IonizingCaveolin 1reviewBreast NeoplasmsErbB ReceptorsGene Expression Regulation Neoplasticbreast cancerCell Transformation NeoplasticCAV1Radiation IonizingBiomarkers TumorAnimalsHumansbiomarkerFemaleMolecular Targeted TherapyReceptor Epidermal Growth Factorionizing radiationBreast NeoplasmHuman
researchProduct